Meng and colleagues reported that higher levels of miR155, both in plasma EVs from patients and in 786–0 and Caki-1 RCC cell lines, resulted in suppressed forkhead box O3 (FOXO3) expression and promotion of RCC cell growth38. The gene discussed is FOXO3; the disease is renal cell carcinoma.